-41.3%
CORZ vs MRNA
+945.0%
-986.3%
-57.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -10.4% | +13.1% | -23.5% | -10.8% |
| 7D | -14.9% | +20.6% | -35.6% | -15.4% |
| 30D | -23.1% | +27.1% | -50.3% | -23.7% |
| 3M | -44.1% | +353.4% | -397.4% | -48.0% |
| 6M | -39.5% | +446.3% | -485.8% | -47.8% |
| YTD | -12.4% | +776.2% | -788.5% | -34.0% |
| 1Y | -41.3% | +987.9% | -1,029.2% | -56.7% |
| All | -41.3% | +945.0% | -986.3% | -56.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling